000 | 01931 a2200529 4500 | ||
---|---|---|---|
005 | 20250513132312.0 | ||
264 | 0 | _c20000728 | |
008 | 200007s 0 0 eng d | ||
022 | _a1059-1524 | ||
024 | 7 |
_a10.1091/mbc.8.12.2449 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aRusnati, M | |
245 | 0 | 0 |
_aalphavbeta3 integrin mediates the cell-adhesive capacity and biological activity of basic fibroblast growth factor (FGF-2) in cultured endothelial cells. _h[electronic resource] |
260 |
_bMolecular biology of the cell _cDec 1997 |
||
300 |
_a2449-61 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAmino Acid Motifs |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntibodies _ximmunology |
650 | 0 | 4 |
_aCalcium _xpharmacology |
650 | 0 | 4 | _aCattle |
650 | 0 | 4 |
_aCell Adhesion _xdrug effects |
650 | 0 | 4 | _aCell Line |
650 | 0 | 4 | _aCricetinae |
650 | 0 | 4 |
_aEndothelium, Vascular _xcytology |
650 | 0 | 4 |
_aFibroblast Growth Factor 2 _xantagonists & inhibitors |
650 | 0 | 4 |
_aFibronectins _xmetabolism |
650 | 0 | 4 |
_aHeparin _xpharmacology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aMitogens _xantagonists & inhibitors |
650 | 0 | 4 |
_aOligopeptides _xpharmacology |
650 | 0 | 4 |
_aPlastics _xmetabolism |
650 | 0 | 4 | _aProtein Binding |
650 | 0 | 4 | _aProtein Structure, Tertiary |
650 | 0 | 4 |
_aReceptors, Vitronectin _xantagonists & inhibitors |
650 | 0 | 4 |
_aRecombinant Fusion Proteins _xantagonists & inhibitors |
650 | 0 | 4 |
_aSequence Deletion _xgenetics |
650 | 0 | 4 | _aSolubility |
650 | 0 | 4 |
_aUrokinase-Type Plasminogen Activator _xmetabolism |
650 | 0 | 4 |
_aVitronectin _xmetabolism |
700 | 1 | _aTanghetti, E | |
700 | 1 | _aDell'Era, P | |
700 | 1 | _aGualandris, A | |
700 | 1 | _aPresta, M | |
773 | 0 |
_tMolecular biology of the cell _gvol. 8 _gno. 12 _gp. 2449-61 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1091/mbc.8.12.2449 _zAvailable from publisher's website |
999 |
_c9368346 _d9368346 |